日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer

利用循环肿瘤DNA进行分子残留病灶检测,用于早期子宫癌术后监测

Ketch, Peter W; Scalise, Carly Bess; Recio, Fernando; Berman, Tara; Hook, Nicole; Loar, Paul; Arend, Rebecca; Dutta, Punashi; Gentry, Zachary L; Kalashnikova, Ekaterina; Malhotra, Meenakshi; Liu, Minetta C; Vaccarello, Luis; ElNaggar, Adam C; Holloway, Robert; Toboni, Michael D

Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma

子宫浆液性癌和子宫癌肉瘤治疗进展及争议

Toboni, Michael; Kurnit, Katherine; Erickson, Britt; Powell, Matthew; Secord, Angeles Alvarez; Fader, Amanda N

Venous thromboembolism risk for patients with BMI ≥40 kg/m(2) undergoing robotic surgery for endometrial cancer

接受机器人辅助子宫内膜癌手术的BMI≥40 kg/m²患者的静脉血栓栓塞风险

Dinkins, Kaitlyn G; Lee, Grace M; Ketch, Peter W; Toboni, Michael D; Leath, Charles A 3rd; Straughn, J Michael Jr; Boitano, Teresa K L

Management of a complete mole and coexisting fetus in post-dobbs world

后多布斯时代完全性葡萄胎合并胎儿的处理

Garcia, Jordan Barton; Seasely, Angela R; Roland, Damien; Guo, Hua; Boozer, Margaret; Cozzi, Gabriella; Toboni, Michael D

Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study

美国不同地区社会人口学特征与宫颈癌生存率:一项基于国家癌症数据库的研究

Toboni, Michael D; Cohen, Alexander; Gentry, Zachary L; Ostby, Stuart A; Wang, Zhixin; Bae, Sejong; Leath, Charles

GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress

GAS6/AXL 抑制通过增加 DNA 损伤和增强复制压力增强卵巢癌对化疗和 PARP 抑制的敏感性

Mary M Mullen, Elena Lomonosova, Michael D Toboni, Alyssa Oplt, Emily Cybulla, Barbara Blachut, Peinan Zhao, Hollie Noia, Daniel Wilke, Erinn B Rankin, Lindsay M Kuroki, Andrea R Hagemann, Ian S Hagemann, Carolyn K McCourt, Premal H Thaker, David G Mutch, Matthew A Powell, Nima Mosammaparast, Alessa

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer

复发性卵巢癌阴道和直肠周围病变的放射治疗

Johns, E A; Stanley, J A; Toboni, M D; Schwarz, J K; Zhang, F; Hagemann, A R; Fuh, K C; Thaker, P H; McCourt, C K; Mutch, D G; Powell, M A; Khabele, D; Kuroki, L M

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

抑制 AXL 和 VEGF-A 可提高子宫浆液性癌的治疗效果

Michael D Toboni, Elena Lomonosova, Shaina F Bruce, Jo'an I Tankou, Mary M Mullen, Angela Schab, Alyssa Oplt, Hollie Noia, Danny Wilke, Lindsay M Kuroki, Andrea R Hagemann, Carolyn K McCourt, Premal H Thaker, Matthew A Powell, Dineo Khabele, David G Mutch, Katherine C Fuh

Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database

来自国家外科质量改进计划数据库的卵巢癌患者非计划再次手术的预测因素

Toboni, Michael D; Smith, Haller J; Bae, Sejong; Straughn, J Michael Jr; Leath, Charles A 3rd

Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm

转移性/复发性子宫平滑肌肉瘤的系统治疗:范式转变

Arend, Rebecca C; Toboni, Michael D; Montgomery, Allison M; Burger, Robert A; Olawaiye, Alexander B; Monk, Bradley J; Herzog, Thomas J